WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2017184726) BIOMARKERS AND METHODS FOR ASSESSING RESPONSE TO INFLAMMATORY DISEASE THERAPY
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.:    WO/2017/184726    International Application No.:    PCT/US2017/028356
Publication Date: 26.10.2017 International Filing Date: 19.04.2017
IPC:
G01N 33/68 (2006.01), G01N 33/536 (2006.01)
Applicants: EASTMAN, Paul Scott [US/US]; (US).
MANNING, William [US/US]; (US).
CRESCENDO BIOSCIENCE [US/US]; 341 Oyster Point Blvd. South San Francisco, California 94080 (US)
Inventors: EASTMAN, Paul Scott; (US).
MANNING, William; (US)
Agent: ELLIS, Gregory; (US)
Priority Data:
62/324,968 20.04.2016 US
Title (EN) BIOMARKERS AND METHODS FOR ASSESSING RESPONSE TO INFLAMMATORY DISEASE THERAPY
(FR) BIOMARQUEURS ET PROCÉDÉS D'ÉVALUATION DE LA RÉPONSE À UN TRAITEMENT DE MALADIE INFLAMMATOIRE
Abstract: front page image
(EN)Provided herein are methods for assessing response to inflammatory disease therapy. The methods include performing immunoassays to generate scores based on quantitative data for expression of biomarkers relating to inflammatory biomarkers to assess disease activity in inflammatory diseases, e.g., rheumatoid arthritis. Also provided are uses of inflammatory biomarkers for guiding treatment decisions.
(FR)La présente invention concerne des procédés d'évaluation de la réponse à un traitement de maladie inflammatoire. Les procédés comprennent la mise en œuvre de dosages immunologiques pour produire des scores basés sur des données quantitatives d'expression de biomarqueurs liés des biomarqueurs inflammatoires pour évaluer une activité pathologique dans des maladies inflammatoires, par exemple la polyarthrite rhumatoïde. L'invention concerne également des utilisations de biomarqueurs inflammatoires pour guider des décisions de traitement.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)